Cedric Francois

Insider Reports History

Entity
Individual
Location
6400 Westwind Way, Suite A, Crestwood, KY
Signature
/s/ David Watson, attorney-in-fact for Cedric Francois
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cedric Francois:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 654K $43M $65.68 Mar 1, 2024 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023)
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 533K $35M $65.68 Mar 1, 2024 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2)
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 314K $20.6M $65.68 Mar 1, 2024 Direct
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 300K $19.7M $65.68 Mar 1, 2024 Indirect Owner (The Francois Grossi Trust)
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 234K $15.4M $65.68 Mar 1, 2024 Indirect Owner (The Francois-DuBois Educational Trust)
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 176K $11.6M $66.30 Mar 1, 2024 Direct

Insider Reports Filed by Cedric Francois

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Mar 1, 2024 9 -$15M 4 Mar 5, 2024 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Feb 12, 2024 1 -$268K 4 Feb 13, 2024 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Jan 29, 2024 1 -$182K 4 Jan 31, 2024 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Jan 22, 2024 1 -$873K 4 Jan 23, 2024 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Jan 16, 2024 3 $6.43M 4 Jan 17, 2024 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Nov 21, 2023 1 -$244K 4 Nov 21, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Sep 19, 2023 2 $0 4 Sep 20, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Sep 1, 2023 4 -$5.46M 4 Sep 1, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. May 24, 2023 2 $0 4 May 25, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. May 16, 2023 10 -$2.44M 4 May 18, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Apr 27, 2023 2 $0 4 Apr 28, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Apr 18, 2023 5 -$2.33M 4 Apr 20, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Apr 3, 2023 6 $0 4 Apr 5, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Mar 21, 2023 9 -$1.27M 4 Mar 23, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Feb 27, 2023 2 $376K 4 Mar 1, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Feb 21, 2023 3 -$93.7K 4 Feb 22, 2023 Chief Executive Officer
APLS Apellis Pharmaceuticals, Inc. Feb 10, 2023 1 -$203K 4 Feb 14, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Jan 27, 2023 1 -$152K 4 Jan 30, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Jan 20, 2023 1 -$492K 4 Jan 24, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Apr 25, 2022 3 $6.9M 4 Jan 17, 2023 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Apr 25, 2022 9 -$1.24M 4 Dec 21, 2022 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Feb 10, 2022 1 -$119K 4 Feb 14, 2022 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Jan 28, 2022 1 -$78.1K 4 Feb 1, 2022 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Jan 21, 2022 2 $0 4 Jan 25, 2022 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Dec 31, 2021 1 $0 5 Feb 10, 2022 Chief Executive Officer, Director
APLS Apellis Pharmaceuticals, Inc. Jul 21, 2021 2 $62.1K 4 Jul 22, 2021 Chief Executive Officer, Director